TFRI’s leadership and research community are mourning and paying tribute to Dr. Philip (Phil) Branton, who dedicated his life to cancer research and the advancement of it in Canada. He had… Read More
NanoVation will receive research funding and is eligible to receive up to approximately US$600 million in up-front cash and potential milestone payments, as well as tiered royalties on future product… Read More
Message from Dr. Elinor Wilson Chair, Board of Directors After eight years as President & CEO of Michael Smith Health Research BC, Dr. Bev Holmes has informed the Board of… Read More
Labcorp has more than 20 years of molecular bioanalytical experience and has supported the development of more than 70 novel therapies to date Expansion supports the development of advanced cell… Read More
SPIKEVAX® is the first updated COVID-19 vaccine authorized in Canada for 2024-2025, offering a timely solution to help protect Canadians this fall and winter season. Moderna will promptly begin delivery… Read More
